{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:48Z","timestamp":1793082828781,"version":"4.5.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T00:00:00Z","timestamp":1611273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00467-021-04921-3","type":"journal-article","created":{"date-parts":[[2021,1,22]],"date-time":"2021-01-22T09:19:29Z","timestamp":1611307169000},"page":"2687-2695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Use of diuretics in the neonatal period"],"prefix":"10.1007","volume":"36","author":[{"given":"Jean-Pierre","family":"Guignard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6243-0909","authenticated-orcid":false,"given":"Silvia","family":"Iacobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,22]]},"reference":[{"key":"4921_CR1","doi-asserted-by":"publisher","first-page":"e0222667","DOI":"10.1371\/journal.pone.0222667","volume":"14","author":"B Gouyon","year":"2019","unstructured":"Gouyon B, Martin-Mons S, Iacobelli S, Razafimahefa H, Kermorvant-Duchemin E, Brat R, Caeymaex L, Couringa Y, Alexandre C, Lafon C, Ramful D, Bonsante F, Binson G, Flamein F, Moussy-Durandy A, Di Maio M, Mazeiras G, Girard O, Desbruyeres C, Mourdie J, Escourrou G, Flechelles O, Abasse S, Rosenthal JM, Pages AS, Dorsi M, Karaoui L, ElGellab A, Le Bail Dantec F, Yangui MA, Norbert K, Kugbe Y, Lorrain S, Pignolet A, Garnier EM, Lapillonne A, Mitanchez D, Jacqz-Aigrain E, Gouyon JB (2019) Characteristics of prescription in 29 Level 3 Neonatal Wards over a 2-year period (2017-2018). An inventory for future research. PLoS One 14:e0222667. https:\/\/doi.org\/10.1371\/journal.pone.0222667","journal-title":"PLoS One"},{"key":"4921_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/jp.2011.11","volume":"31","author":"JI Hagadorn","year":"2011","unstructured":"Hagadorn JI, Sanders MR, Staves C, Herson VC, Daigle K (2011) Diuretics for very low birth weight infants in the first 28 days: a survey of the U.S. neonatologists. J Perinatol 31:677\u2013681. https:\/\/doi.org\/10.1038\/jp.2011.11","journal-title":"J Perinatol"},{"key":"4921_CR3","doi-asserted-by":"publisher","unstructured":"Iacobelli S, Guignard JP (2020) Maturation of glomerular filtration rate in neonates and infants: an overview. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-020-04632-1","DOI":"10.1007\/s00467-020-04632-1"},{"key":"4921_CR4","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1007\/s00467-013-2666-6","volume":"30","author":"J Gattineni","year":"2015","unstructured":"Gattineni J, Baum M (2015) Developmental changes in renal tubular transport\u2014an overview. Pediatr Nephrol 30:2085\u20132098. https:\/\/doi.org\/10.1007\/s00467-013-2666-6","journal-title":"Pediatr Nephrol"},{"key":"4921_CR5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.siny.2016.11.002","volume":"22","author":"JL Segar","year":"2017","unstructured":"Segar JL (2017) Renal adaptive changes and sodium handling in the fetal-to-newborn transition. Semin Fetal Neonatal Med 22:76\u201382. https:\/\/doi.org\/10.1016\/j.siny.2016.11.002","journal-title":"Semin Fetal Neonatal Med"},{"key":"4921_CR6","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1111\/j.1748-1716.2010.02164.x","volume":"200","author":"S Iacobelli","year":"2010","unstructured":"Iacobelli S, Gouyon JB, Bonsante F, Mastrofrancesco L, Svelto M, Valenti G (2010) Aquaporin-2 urinary excretion in preterm infants: relationship to diuresis and vasopressin. Acta Physiol (Oxf) 200:339\u2013345. https:\/\/doi.org\/10.1111\/j.1748-1716.2010.02164.x","journal-title":"Acta Physiol (Oxf)"},{"key":"4921_CR7","doi-asserted-by":"publisher","unstructured":"Adhikari M, Moodley M, Desai PK (1990) Mannitol in neonatal cerebral oedema. Brain Dev 12:349\u2013351. https:\/\/doi.org\/10.1016\/s0387-7604(12)80320-2","DOI":"10.1016\/s0387-7604(12)80320-2"},{"key":"4921_CR8","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1097\/MJT.0b013e31825e792c","volume":"21","author":"B Tam","year":"2014","unstructured":"Tam B, Chhay A, Yen L, Tesoriero L, Ramanathan R, Seri I, Friedlich PS (2014) Acetazolamide for the management of chronic metabolic alkalosis in neonates and infants. Am J Ther 21:477\u2013481. https:\/\/doi.org\/10.1097\/MJT.0b013e31825e792c","journal-title":"Am J Ther"},{"key":"4921_CR9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1177\/1060028013500468","volume":"47","author":"MG Andrews","year":"2015","unstructured":"Andrews MG, Johnson PN, Lammers EM, Harrison DL, Miller JL (2015) Acetazolamide in critically ill neonates and children with metabolic alkalosis. Ann Pharmacother 47:1130\u20131135. https:\/\/doi.org\/10.1177\/1060028013500468","journal-title":"Ann Pharmacother"},{"key":"4921_CR10","doi-asserted-by":"publisher","first-page":"E6","DOI":"10.1542\/peds.108.1.e6","volume":"108","author":"MG Seikaly","year":"2011","unstructured":"Seikaly MG, Baum M (2011) Thiazide diuretics arrest the progression of nephrocalcinosis in children with X-linked hypophosphatemia. Pediatrics 108:E6. https:\/\/doi.org\/10.1542\/peds.108.1.e6","journal-title":"Pediatrics"},{"key":"4921_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/jcpt.12440","volume":"41","author":"N Krzy\u017caniak","year":"2016","unstructured":"Krzy\u017caniak N, Paw\u0142owska I, Bajorek B (2016) Review of drug utilization patterns in NICUs worldwide. J Clin Pharm Ther 41:612\u2013620. https:\/\/doi.org\/10.1111\/jcpt.12440","journal-title":"J Clin Pharm Ther"},{"key":"4921_CR12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13052-020-00851-2","volume":"46","author":"VA Manfredini","year":"2020","unstructured":"Manfredini VA, Cerini C, Clavenna A, Dotta A, Caccamo ML, Staffler A, Massenzi L, Rezzonico RM, Study Group of Neonatal Pharmacotherapy of the Italian Society of Neonatology (2020) Furosemide use in Italian neonatal intensive care units: a national survey. Ital J Pediatr 46:86. https:\/\/doi.org\/10.1186\/s13052-020-00851-2","journal-title":"Ital J Pediatr"},{"key":"4921_CR13","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s001340000819","volume":"27","author":"MM van der Vorst","year":"2001","unstructured":"van der Vorst MM, Ruys-Dudok van Heel I, Kist-van Holthe JE, den Hartigh J, Schoemaker RC, Cohen AF, Burggraaf J (2001) Continuous intravenous furosemide in haemodynamically unstable children after cardiac surgery. Intensive Care Med 27:711\u2013715. https:\/\/doi.org\/10.1007\/s001340000819","journal-title":"Intensive Care Med"},{"key":"4921_CR14","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1111\/j.1365-2125.2007.02913.x","volume":"64","author":"MMG van der Vorst","year":"2007","unstructured":"van der Vorst MMG, Kist-van Holthe JE, den Hartigh J, van der Heijden AJ, Cohen AF, Burggraaf J (2007) Absence of tolerance and toxicity to high-dose continuous intravenous furosemide in haemodynamically unstable infants after cardiac surgery. Br J Clin Pharmacol 64:796\u2013803. https:\/\/doi.org\/10.1111\/j.1365-2125.2007.02913.x","journal-title":"Br J Clin Pharmacol"},{"key":"4921_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s001340050395","volume":"23","author":"JM Klinge","year":"1997","unstructured":"Klinge JM, Scharf J, Hofbeck M, Gerling S, Bonakdar S, Singer H (1997) Intermittent administration of furosemide versus continuous infusion in the postoperative management of children following open heart surgery. Intensive Care Med 23:693\u2013697. https:\/\/doi.org\/10.1007\/s001340050395","journal-title":"Intensive Care Med"},{"key":"4921_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/0002-9149(80)90650-5","volume":"45","author":"BG Baylen","year":"1980","unstructured":"Baylen BG, Johnson G, Tsang R, Srivastava L, Kaplan S (1980) The occurrence of hyperaldosteronism in infants with congestive heart failure. Am J Cardiol 45:305\u2013310. https:\/\/doi.org\/10.1016\/0002-9149(80)90650-5","journal-title":"Am J Cardiol"},{"key":"4921_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2165\/11596620-000000000-00000","volume":"14","author":"G Pacifici","year":"2012","unstructured":"Pacifici G (2012) Clinical pharmacology of the loop diuretics furosemide and bumetanide in neonates and infants. Pediatr Drugs 14:233\u2013246. https:\/\/doi.org\/10.2165\/11596620-000000000-00000","journal-title":"Pediatr Drugs"},{"key":"4921_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fped.2020.00260","volume":"8","author":"N Sutiman","year":"2020","unstructured":"Sutiman N, Koh JC, Watt K, Hornik C, Murphy B, Chan YH, Lee JH (2020) Pharmacokinetics alterations in critically ill pediatric patients on extracorporeal membrane oxygenation: a systematic review. Front Pediatr 8:260. https:\/\/doi.org\/10.3389\/fped.2020.00260","journal-title":"Front Pediatr"},{"key":"4921_CR19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00467-007-0633-9","volume":"24","author":"H Jalanko","year":"2009","unstructured":"Jalanko H (2009) Congenital nephrotic syndrome. Pediatr Nephrol 24:2121\u20132128. https:\/\/doi.org\/10.1007\/s00467-007-0633-9","journal-title":"Pediatr Nephrol"},{"key":"4921_CR20","doi-asserted-by":"publisher","unstructured":"H\u00f6ltt\u00e4 T, Jalanko H (2020) Congenital nephrotic syndrome: is early aggressive treatment needed? Yes. Pediatr Nephrol. https:\/\/doi.org\/10.1007\/s00467-020-04578-4","DOI":"10.1007\/s00467-020-04578-4"},{"key":"4921_CR21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2147\/PHMT.S193684","volume":"10","author":"BC Reynolds","year":"2019","unstructured":"Reynolds BC, Oswald RJA (2019) Diagnostic and management challenges in congenital nephrotic syndrome. Pediatric Health Med Ther 10:157\u2013167. https:\/\/doi.org\/10.2147\/PHMT.S193684","journal-title":"Pediatric Health Med Ther"},{"key":"4921_CR22","first-page":"60","volume":"9","author":"SM Bagshaw","year":"2007","unstructured":"Bagshaw SM, Delaney A, Haase M, Ghali WA, Bellomo R (2007) Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc 9:60\u201368","journal-title":"Crit Care Resusc"},{"key":"4921_CR23","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1203\/00006450-200004000-00015","volume":"47","author":"L Dubourg","year":"2000","unstructured":"Dubourg L, Drukker A, Guignard JP (2000) Failure of torasemide to improve renal function of hypoxemic vasomotor nephropathy in the newborn rabbit. Pediatr Res 47:504\u2013508. https:\/\/doi.org\/10.1203\/00006450-200004000-00015","journal-title":"Pediatr Res"},{"key":"4921_CR24","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1007\/s004670050068","volume":"14","author":"JB Gouyon","year":"2000","unstructured":"Gouyon JB, Guignard JP (2000) Management of acute renal failure in newborns. Pediatr Nephrol 14:1037\u20131044. https:\/\/doi.org\/10.1007\/s004670050068","journal-title":"Pediatr Nephrol"},{"key":"4921_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1055\/s-0035-1564735","volume":"5","author":"JP Guignard","year":"2016","unstructured":"Guignard JP, Ali US (2016) Acute renal failure in the neonate. J Pediatr Intensive Care 5:42\u201349. https:\/\/doi.org\/10.1055\/s-0035-1564735","journal-title":"J Pediatr Intensive Care"},{"key":"4921_CR26","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.siny.2016.12.001","volume":"22","author":"A Nada","year":"2017","unstructured":"Nada A, Bonachea EM, Askenazi DJ (2017) Acute kidney injury in the fetus and neonate. Semin Fetal Neonatal Med 22:90\u201397. https:\/\/doi.org\/10.1016\/j.siny.2016.12.001","journal-title":"Semin Fetal Neonatal Med"},{"key":"4921_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15171\/jrip.2017.01","volume":"6","author":"V Pandey","year":"2016","unstructured":"Pandey V, Kumar D, Vijayaraghavan P, Chaturvedi T, Raina R (2016) Non-dialytic management of acute kidney injury in newborns. J Renal Inj Prev 6:1\u201311. https:\/\/doi.org\/10.15171\/jrip.2017.01","journal-title":"J Renal Inj Prev"},{"key":"4921_CR28","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/PCC.0000000000001478","volume":"19","author":"S Borasino","year":"2018","unstructured":"Borasino S, Wall KM, Crawford JH, Hock KM, Cleveland DC, Rahman F, Martin KD, Alten JA (2018) Furosemide response predicts acute kidney injury after cardiac surgery in infants and neonates. Pediatr Crit Care Med 19:310\u2013317. https:\/\/doi.org\/10.1097\/PCC.0000000000001478","journal-title":"Pediatr Crit Care Med"},{"key":"4921_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/PCC.0b013e3181e912a7","volume":"12","author":"M Oliveros","year":"2011","unstructured":"Oliveros M, Pham JT, John E, Resheidat A, Bhat R (2011) The use of bumetanide for oliguric acute renal failure in preterm infants. Pediatr Crit Care Med 12:210\u2013214. https:\/\/doi.org\/10.1097\/PCC.0b013e3181e912a7","journal-title":"Pediatr Crit Care Med"},{"key":"4921_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.15401\/jcpn\/2014\/v2i1\/50526","volume":"2","author":"RC Merheb","year":"2014","unstructured":"Merheb RC, Kruzer KA, Mhanna MJ (2014) The effect of bumetanide in extremely low birth weight infants with acute kidney injury during their first weeks of life. J Clin Pediatr Nephrol 2:53\u201363. https:\/\/doi.org\/10.15401\/jcpn\/2014\/v2i1\/50526","journal-title":"J Clin Pediatr Nephrol"},{"key":"4921_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.15401\/jcpn\/2014\/v2i2\/66346","volume":"2","author":"V Pandey","year":"2015","unstructured":"Pandey V, Dummula K, Go M, Parimi P (2015) Bumetanide use in the management of oliguric preterm infants with acute kidney injury\u2013a single center experience. J Clin Pediatr Nephrol 2:33\u201338. https:\/\/doi.org\/10.15401\/jcpn\/2014\/v2i2\/66346","journal-title":"J Clin Pediatr Nephrol"},{"key":"4921_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1159\/000242796","volume":"53","author":"JB Gouyon","year":"1988","unstructured":"Gouyon JB, Guignard JP (1988) Functional renal insufficiency: role of adenosine. Biol Neonate 53:237\u2013242. https:\/\/doi.org\/10.1159\/000242796","journal-title":"Biol Neonate"},{"key":"4921_CR33","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1159\/000457592","volume":"13","author":"JB Gouyon","year":"1989","unstructured":"Gouyon JB, Guignard JP (1989) Adenosine in the immature kidney. Dev Pharmacol Ther 13:113\u2013119. https:\/\/doi.org\/10.1159\/000457592","journal-title":"Dev Pharmacol Ther"},{"key":"4921_CR34","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/ki.1988.114","volume":"33","author":"JB Gouyon","year":"1988","unstructured":"Gouyon JB, Guignard JP (1988) Theophylline prevents the hypoxemia-induced renal hemodynamic changes in rabbits. Kidney Int 33:1078\u20131083. https:\/\/doi.org\/10.1038\/ki.1988.114","journal-title":"Kidney Int"},{"key":"4921_CR35","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1136\/archdischild-2018-315805","volume":"104","author":"GC Bhatt","year":"2019","unstructured":"Bhatt GC, Gogia P, Bitzan M, Das RR (2019) Theophylline and aminophylline for prevention of acute kidney injury in neonates and children: a systematic review. Arch Dis Child 104:670\u2013679. https:\/\/doi.org\/10.1136\/archdischild-2018-315805","journal-title":"Arch Dis Child"},{"key":"4921_CR36","doi-asserted-by":"publisher","unstructured":"Bellos I, Pandita A, Yachha M (2019) Effectiveness of theophylline administration in neonates with perinatal asphyxia: a meta-analysis. J Matern Fetal Neonatal Med. https:\/\/doi.org\/10.1080\/14767058.2019.1673722","DOI":"10.1080\/14767058.2019.1673722"},{"key":"4921_CR37","doi-asserted-by":"publisher","unstructured":"Chock VY, Cho SH, Frymoyer A (2020) Aminophylline for renal protection in neonatal hypoxic-ischemic encephalopathy in the era of therapeutic hypothermia. Pediatr Res. https:\/\/doi.org\/10.1038\/s41390-020-0999-y","DOI":"10.1038\/s41390-020-0999-y"},{"key":"4921_CR38","doi-asserted-by":"publisher","first-page":"3","DOI":"10.4172\/2167-0897.1000261","volume":"06","author":"D Sharma","year":"2019","unstructured":"Sharma D (2019) Hypertension in neonates: need for future research. J Neonatal Biol 06:3. https:\/\/doi.org\/10.4172\/2167-0897.1000261","journal-title":"J Neonatal Biol"},{"key":"4921_CR39","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/BF00867488","volume":"5","author":"U Alon","year":"1991","unstructured":"Alon U, Hellerstein S, Warady BA (1991) Oral acetazolamide in the assessment of (urine-blood) PCO2. Pediatr Nephrol 5:307\u2013311. https:\/\/doi.org\/10.1007\/BF00867488","journal-title":"Pediatr Nephrol"},{"key":"4921_CR40","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0140-6736(16)00087-8","volume":"388","author":"LA Plumb","year":"2016","unstructured":"Plumb LA, Van't Hoff W, Kleta R, Reid C, Ashton E, Samuels M, Bockenhauer D (2016) Renal apnoea: extreme disturbance of homoeostasis in a child with Bartter syndrome type IV. Lancet 388:631\u2013632. https:\/\/doi.org\/10.1016\/S0140-6736(16)00087-8","journal-title":"Lancet"},{"key":"4921_CR41","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/ade.80.6.548","volume":"80","author":"V Kirchlechner","year":"1999","unstructured":"Kirchlechner V, Koller D, Seidl, Waldhauser F (1999) Treatment of nephrogenic diabetes insipidus with hydrochlorothiazide and amiloride. Arch Dis Child 80:548\u2013552. https:\/\/doi.org\/10.1136\/ade.80.6.548","journal-title":"Arch Dis Child"},{"key":"4921_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/ph6091094","volume":"6","author":"GM Pacifici","year":"2013","unstructured":"Pacifici GM (2013) Clinical pharmacology of furosemide in neonates: a review. Pharmaceuticals (Basel) 6:1094\u20131129. https:\/\/doi.org\/10.3390\/ph6091094","journal-title":"Pharmaceuticals (Basel)"},{"key":"4921_CR43","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1365-2125.2012.04257.x","volume":"74","author":"M Suyagh","year":"2012","unstructured":"Suyagh M, Hawwa AF, Collier PS, Millership JS, Kole P, Millar M, Shields MD, Halliday HL, McElnay JC (2012) Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients. Br J Clin Pharmacol 74:864\u2013872. https:\/\/doi.org\/10.1111\/j.1365-2125.2012.04257.x","journal-title":"Br J Clin Pharmacol"},{"key":"4921_CR44","doi-asserted-by":"publisher","first-page":"e410","DOI":"10.1542\/neo.13-7-e410","volume":"13","author":"M Bestic","year":"2012","unstructured":"Bestic M, Reed MD (2012) Common diuretics used in the preterm and term infant. NeoReviews 13:e410\u2013e419. https:\/\/doi.org\/10.1542\/neo.13-7-e410","journal-title":"NeoReviews"},{"key":"4921_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.clp.2011.12.007","volume":"39","author":"JL Segar","year":"2012","unstructured":"Segar JL (2012) Neonatal diuretic therapy: furosemide, thiazides, and spironolactone. Clin Perinatol 39:209\u2013220. https:\/\/doi.org\/10.1016\/j.clp.2011.12.007","journal-title":"Clin Perinatol"},{"key":"4921_CR46","doi-asserted-by":"publisher","first-page":"CD001454","DOI":"10.1002\/14651858.CD001454.pub3","volume":"1","author":"A Stewart","year":"2011","unstructured":"Stewart A, Brion LP, Soll RF (2011) Diuretics for respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev 1:CD001454. https:\/\/doi.org\/10.1002\/14651858.CD001454.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"4921_CR47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jpeds.2018.01.066","volume":"197","author":"CJ Blaisdell","year":"2018","unstructured":"Blaisdell CJ, Troendle J, Zajicek A (2018) Prematurity and respiratory outcomes program. Acute Responses to Diuretic Therapy in Extremely Low Gestational Age Newborns: Results from the Prematurity and Respiratory Outcomes Program Cohort Study. J Pediatr 197:42\u201347. https:\/\/doi.org\/10.1016\/j.jpeds.2018.01.066","journal-title":"J Pediatr"},{"key":"4921_CR48","doi-asserted-by":"publisher","first-page":"CD003064","DOI":"10.1002\/14651858.CD003064.pub3","volume":"11","author":"M Kassab","year":"2015","unstructured":"Kassab M, Khriesat WM, Anabrees J (2015) Diuretics for transient tachypnoea of the newborn. Cochrane Database Syst Rev 11:CD003064. https:\/\/doi.org\/10.1002\/14651858.CD003064.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"4921_CR49","doi-asserted-by":"publisher","first-page":"117955651881732","DOI":"10.1177\/1179556518817322","volume":"12","author":"Z Michael","year":"2018","unstructured":"Michael Z, Spyropoulos F, Ghanta S, Christou H (2018) Bronchopulmonary dysplasia: an update of current pharmacologic therapies and new approaches. Clin Med Insights Pediatr 12:1179556518817322. https:\/\/doi.org\/10.1177\/1179556518817322","journal-title":"Clin Med Insights Pediatr"},{"key":"4921_CR50","first-page":"CD001453","volume":"9","author":"A Stewart","year":"2011","unstructured":"Stewart A, Brion LP (2011) Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 9:CD001453","journal-title":"Cochrane Database Syst Rev"},{"key":"4921_CR51","first-page":"CD001694","volume":"2","author":"LP Brion","year":"2006","unstructured":"Brion LP, Primhak RA, Yong W (2006) Aerosolized diuretics for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 2:CD001694","journal-title":"Cochrane Database Syst Rev"},{"key":"4921_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpeds.2018.11.043","volume":"208","author":"RG Greenberg","year":"2019","unstructured":"Greenberg RG, Gayam S, Savage D, Tong A, Gorham D, Sholomon A, Clark RH, Benjamin DK, Laughon M, Smith PB, Best Pharmaceuticals for Children Act\u2014Pediatric Trials Network Steering Committee (2019) Furosemide exposure and prevention of bronchopulmonary dysplasia in premature infants. J Pediatr 208:134\u2013140.e2. https:\/\/doi.org\/10.1016\/j.jpeds.2018.11.043","journal-title":"J Pediatr"},{"key":"4921_CR53","first-page":"CD001817","volume":"9","author":"A Stewart","year":"2011","unstructured":"Stewart A, Brion LP, Ambrosio-Perez I (2011) Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease. Cochrane Database Syst Rev 9:CD001817","journal-title":"Cochrane Database Syst Rev"},{"key":"4921_CR54","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1056\/NEJMoa054065","volume":"354","author":"B Schmidt","year":"2006","unstructured":"Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W, Caffeine for Apnea of Prematurity Trial Group (2006) Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112\u20132121. https:\/\/doi.org\/10.1056\/NEJMoa054065","journal-title":"N Engl J Med"},{"key":"4921_CR55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1159\/000289206","volume":"98","author":"BS Lee","year":"2010","unstructured":"Lee BS, Byun SY, Chung ML, Chang JY, Kim HY, Kim EA, Kim KS, Pi SY (2010) Effect of furosemide on ductal closure and renal function in indomethacin-treated preterm infants during the early neonatal period. Neonatology 98:191\u2013199. https:\/\/doi.org\/10.1159\/000289206","journal-title":"Neonatology"},{"key":"4921_CR56","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jpeds.2018.03.067","volume":"199","author":"EJ Thompson","year":"2018","unstructured":"Thompson EJ, Greenberg RG, Kumar K (2018) Association between furosemide exposure and patent ductus arteriosus in hospitalized infants of very low birth weight. J Pediatr 199:231\u2013236. https:\/\/doi.org\/10.1016\/j.jpeds.2018.03.067","journal-title":"J Pediatr"},{"key":"4921_CR57","doi-asserted-by":"publisher","unstructured":"Iacobelli S, Lorrain S, Gouyon B, Gambacorta S, Laforgia N, Gouyon JB, Bonsante F (2020) Drug exposure for PDA closure in France: a prospective, cohort-based, analysis. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-020-02974-1","DOI":"10.1007\/s00228-020-02974-1"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-021-04921-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-021-04921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T06:09:14Z","timestamp":1629180554000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-021-04921-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,22]]},"references-count":57,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["4921"],"URL":"https:\/\/doi.org\/10.1007\/s00467-021-04921-3","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,22]]},"assertion":[{"value":"2 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}